Abbott Laboratories (ABT) Inventory (2009 - 2026)

Abbott Laboratories has disclosed Inventory across 18 years of filings, most recently posting $7.3 billion for Q2 2026.

• In Q2 2026, Inventory rose 5.19% year-over-year to $7.3 billion; the TTM figure through Jun 2026 stood at $7.3 billion (up 5.19% YoY), while the FY2025 annual figure was $6.5 billion, up 4.75% from the prior year.
• Inventory came in at $7.3 billion for Q2 2026 at Abbott Laboratories, up from $7.0 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $7.3 billion in Q2 2026 to a low of $5.7 billion in Q1 2022.
• Average Inventory over 5 years is $6.6 billion, with a median of $6.7 billion recorded in 2023.
• Year-over-year, Inventory advanced 19.7% in 2022 and decreased 5.72% in 2024.
• Over 5 years, Inventory stood at $6.2 billion in 2022, then advanced by 6.43% to $6.6 billion in 2023, then declined by 5.72% to $6.2 billion in 2024, then gained by 4.75% to $6.5 billion in 2025, then grew by 12.75% to $7.3 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $7.3 billion in Q2 2026, $7.0 billion in Q1 2026, and $6.5 billion in Q4 2025.